Last reviewed · How we verify
NCT03701893: PROFEC
Evaluate the Use of a New Probiotic Strain in Couples With Fertility Problems and Dysbiosis.
NA trial testing Lactobacillus PS11610 in Infertility in 30 participants. Completed in 31 December 2019.
31 December 2019
Quick facts
| Lead sponsor | ProbiSearch SL |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 30 |
| Start date | 22 October 2018 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Lactobacillus PS11610
Conditions studied
- Infertility — all drugs for Infertility →
- Vaginal Flora Imbalance — all drugs for Vaginal Flora Imbalance →
- Genital Disorder — all drugs for Genital Disorder →
Sponsor
ProbiSearch SL — full company profile →
Who can join
Adults 20 to 40, any sex, with Infertility or Vaginal Flora Imbalance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pilot study to evaluate the effect of the strain Lactobacillus PS11610 on the microbiota of the female and male genital tract in couples with fertility problems. Couples who have started treatment for artificial insemination or who are on the waiting list for an invitro fertilization treatment will be invited to participate. The estimated duration of the study will be 7 and a half months.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03701893
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility
Currently open trials in the same condition.
- NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
- NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
- NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
- NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
Other ProbiSearch SL trials
Trials by the same sponsor.
- NCT04937556 — Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19 (Coronavirus Disease). · NA · completed
- NCT03671486 — Colonization with Group B Streptococcus During Pregnancy · completed
- NCT03669094 — Effect of a New Probiotic Strain in the Reduction of Group B Streptococcus Colonization in Pregnant Women · NA · completed
- NCT03701906 — Effect of a Mixture of New Probiotic Strains in Preterm Infants · NA · completed
- NCT03614117 — Effect of a New Probiotic Strain on Recurrent Acute Otitis Media in Children (PROMAR) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03701893 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ProbiSearch SL
- Last refreshed: 22 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03701893.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing